Alzheimers Drug Access Explainer

2023. 2. 4. 22:38
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

FILE - This Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. Leqembi, the first drug to show that it slows Alzheimer’s, was approved by the U.S. Food and Drug Administration in early January 2023, but treatment for most patients is still several months away. Two big factors behind the slow debut, according to experts, are scant insurance coverage and a long setup time needed by many health systems. (Eisai via AP, File) AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDIT

▶제보는 카톡 okjebo

Copyright © 연합뉴스. 무단전재 -재배포, AI 학습 및 활용 금지

이 기사에 대해 어떻게 생각하시나요?